An intensive study comparison has been carried out for several IGFs, IGFBPs and PAPP-A levels between 301 patients (with early BC treated by surgery, with and without adjuvant treatments) and 531 non-cancer individuals as controls [101]. This evidence concerns the gene PAPPA and breast cancer.